• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Childhood lead exposure linked with lower socioeconomic status and cognition in middle age

byMichael MilliganandDaniel Fisher
March 31, 2017
in Chronic Disease, Neurology, Pediatrics, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this prospective cohort study, New Zealand children with increased lead levels in their blood had significantly lower cognitive skills and socioeconomic status in adulthood compared to children with lower lead levels.

2. The link between childhood lead levels and lower adulthood socioeconomic status was primarily mediated through cognitive decline.

Evidence Rating Level: Good

Study Rundown: Environmental protection policies are being increasingly scrutinized in the United States, especially since the events concerning lead contamination in Flint, Michigan. While it’s known that childhood lead exposure leads to serious neurological deficits, few studies have assessed the impact of this exposure into adulthood. In a prospective cohort study, children from New Zealand were followed until 38 years old, and IQ and socioeconomic status were recorded. The New Zealand cohort is especially informative because high lead levels were driven by automobile emissions and childhood blood lead concentrations were independent of socioeconomic status (SES) and IQ. At 38 years of age, higher childhood lead levels were proportionately associated with reduced SES and cognitive abilities. IQ was demonstrated to be a significant mediator of the association between SES change and childhood lead levels, and a sensitivity analysis and further adjustments for covariates were unable to attenuate this findings.

The natural design of this study, in that children were exposed to lead at levels independent of SES, increases the weight of these findings. While effect sizes were comparatively small, they were proportional to other childhood risk factors, like very low birthweight. The economic impact of higher lead levels are hard to assess, but the pervasiveness of these findings should be especially noted by health care providers and policy makers.

Click to read the study in JAMA

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 33

The Scan by 2 Minute Medicine®: Declining Donations, Metals in Food, Unmasking the Mystery of MS and Cold Snap Safety:

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

Relevant Reading: Low-Level Environmental Lead Exposure and Children’s Intellectual Function: An International Pooled Analysis

In-Depth [prospective cohort study]: A total of 565 children from New Zealand were tested for lead levels at age 11 and followed until age 38. Adult participants were then assessed for IQ and SES. Because lead was used in gasoline during the 70’s and 80’s in New Zealand, children of all SES were affected nearly equally in terms of lead exposure, making this cohort distinct from those of other developed nations where blood lead concentrations were correlated with childhood SES. IQ was assessed with the Wechsler Adult Intelligence Scale-IV (WAIS-IV) and SES by the New Zealand Socioeconomic Index-2006 (NZSEI-06). For each 5mg/dl increase in lead exposure, IQ decreased by 1.61 points (CI95 -2.48 to -0.74) and SES by 1.79 (CI95 -3.17 to -0.40), after controlling for childhood IQ, childhood SES, and mother’s IQ. Additionally, those with lead levels below 10mg/dL showed an increase in IQ of 1.22 while those above showed a decreased IQ of 1.68, resulting in a significant difference of 2.10 between groups (CI95 0.19 to 3.99). IQ decline accounted for 40% of the association between childhood lead levels and SES change (p = 0.002).

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: childhood cognitioncognitive developmentleadlead poisoning
Previous Post

Study suggests shift away from pharmacologic management of patent ductus arteriosus

Next Post

Extended rivaroxaban superior to aspirin in lowering risk of recurrent venous thromboembolism: The EINSTEIN CHOICE trial

RelatedReports

The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 33

January 25, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Declining Donations, Metals in Food, Unmasking the Mystery of MS and Cold Snap Safety:

January 23, 2024
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

January 25, 2023
Foster placement not sole factor in lagging academic achievement
Chronic Disease

Preterm birth linked to higher incidence of severe neurodevelopmental disabilities at age 5

May 28, 2021
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Extended rivaroxaban superior to aspirin in lowering risk of recurrent venous thromboembolism: The EINSTEIN CHOICE trial

Multiple-electrode switching radiofrequency ablation may successfully treat lung tumors

Non-malignant extrapulmonary findings common in lung cancer screening program

Nicotine biomarker predicts rates of smoking cessation in response to varenicline or nicotine patch

Nicotine ameliorates schizophrenia cognitive deficits in mice [PreClinical]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medbridge turns any phone into a motion-capture coach for at-home rehab
  • Structured exercise intervention improves survival in colon cancer patients
  • #VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.